← Leaderboards
Elena Aikawa
Boston University Medical Campus
$10,614,721
Attributed
$17,548,318
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,548,318 · 7
By mechanism
R01$17,538,826 · 6
P41$9,492 · 1
Top collaborators
- Joyce E. Bischoff8 shared
- Robert A Levine8 shared
- Masanori Aikawa2 shared
- Sasha A Singh2 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- James Athur Hamilton$7,064,056
- Allan J. Walkey$9,287,275
- Gail E Sonenshein$16,606,360
- Barbara Davis Smith$3,587,841
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VitroIn VivoMolecularMediatingEventBaseInterstitial CellRepairedProteomicsPhenotypeResolutionPathway InteractionsCalcificationMineralizationBreast MicrocalcificationMolecular ImagingImaging ModalityMouse ModelAreaNational Heart, Lung, And Blood InstituteGeneticLinkNew Therapeutic Target
Grant awards (24)
Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV$739,827
R01 · FY2025 · HL
Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV$771,902
R01 · FY2024 · HL
New driver of fibrosis and calcification in CAVD$587,189
R01 · FY2022 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,383,663
R01 · FY2021 · HL
New driver of fibrosis and calcification in CAVD$587,189
R01 · FY2021 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,383,663
R01 · FY2020 · HL
Macrophage-derived microcalcificaitons$661,115
R01 · FY2020 · HL · contact PI
New driver of fibrosis and calcification in CAVD$587,189
R01 · FY2020 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,377,128
R01 · FY2019 · HL
Macrophage-derived microcalcificaitons$664,893
R01 · FY2019 · HL · contact PI
New driver of fibrosis and calcification in CAVD$607,627
R01 · FY2019 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,413,244
R01 · FY2018 · HL
Macrophage-derived microcalcificaitons$668,485
R01 · FY2018 · HL · contact PI
Macrophage-derived microcalcificaitons$710,801
R01 · FY2017 · HL · contact PI
Aortic valve microcalcification$415,740
R01 · FY2016 · HL · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$800,185
R01 · FY2015 · HL
Aortic valve microcalcification$409,503
R01 · FY2015 · HL · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$814,287
R01 · FY2014 · HL
Aortic valve microcalcification$407,425
R01 · FY2014 · HL · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$810,817
R01 · FY2013 · HL
Aortic valve microcalcification$395,784
R01 · FY2013 · HL · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$905,680
R01 · FY2012 · HL
Aortic valve microcalcification$435,490
R01 · FY2012 · HL · contact PI
NOTCH SIGNALING IN REGULATION OF OSTEOGENIC FATE OF MESENCHYMAL STEM CELLS$9,492
P41 · FY2009 · RR · contact PI